{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:28:19Z","timestamp":1792301299811,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T00:00:00Z","timestamp":1644710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T00:00:00Z","timestamp":1644710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperlipidemia (HLP) and hypertension (HTN) are both independent risk factors for ischemic stroke. This study aimed to assess whether HTN and HLP have a synergistic effect on the risk of ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January and August 2013, 11,695 subjects in rural areas of northeastern China were enrolled. The additive and multiplicative scales were used to evaluate the interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of ischemic stroke was 5.7%. Using the healthy group (without HTN or HLP) as the reference group, subjects with both HTN and HLP had a higher risk of ischemic stroke (odds ratio [OR]: 3.369, 95% confidence interval [CI]: 2.579\u20134.402), and this OR was greater than that of subjects with only HTN (OR: 1.995, 95% CI 1.526\u20132.610) or HLP (OR: 1.321, 95% CI 0.937\u20131.862) (adjusting for age, sex, race, education level, family income, current smoking and drinking status, physical activity, body mass index, diabetes, family history of stroke, and atrial fibrillation). Regarding the additive scale, the relative excess risk due to interaction (OR: 1.053, 95% CI 0.458\u20131.648) was positive after adjusting for confounders. Moreover, the attributable proportion was 31.3%, which means that 31.3% of the total risk of ischemic stroke was due to the synergistic interaction between HTN and HLP. Furthermore, the synergistic index (S) of ischemic stroke was 1.8 (95% CI 1.157\u20132.801), which also indicates a synergistic interaction between HTN and HLP. Regarding the multiplicative scale, the interaction effect was also significant after adjusting for confounders (OR: 2.163, 95% CI 1.817\u20132.575).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results suggest that the synergistic effect of HTN and HLP on ischemic stroke is significantly higher than the sum of their independent effects. The quantification of the combined effect should help to promote healthy blood pressure and blood lipid levels among the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-02491-2","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T16:02:28Z","timestamp":1644768148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China"],"prefix":"10.1186","volume":"22","author":[{"given":"Chang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,13]]},"reference":[{"key":"2491_CR1","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.","journal-title":"PLoS Med."},{"key":"2491_CR2","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1161\/STROKEAHA.111.635755","volume":"42","author":"L Liu","year":"2011","unstructured":"Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42:3651\u20134.","journal-title":"Stroke"},{"key":"2491_CR3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1212\/WNL.0000000000001175","volume":"84","author":"J Wang","year":"2015","unstructured":"Wang J, An Z, Li B, et al. Increasing stroke incidence and prevalence of risk factors in a low-income Chinese population. Neurology. 2015;84:374\u201381.","journal-title":"Neurology"},{"key":"2491_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annemergmed.2014.03.004","volume":"64","author":"J Miller","year":"2014","unstructured":"Miller J, Kinni H, Lewandowski C, et al. Management of hypertension in stroke. Ann Emerg Med. 2014;64:248\u201355.","journal-title":"Ann Emerg Med"},{"key":"2491_CR5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103\u201316.","journal-title":"N Engl J Med"},{"key":"2491_CR6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/HJH.0000000000002826","volume":"39","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, Wang A, Wu S, et al. Antihypertensive treatment decrease stroke occurrence: a prospective cohort study. J Hypertens. 2021;39:1652\u201361.","journal-title":"J Hypertens"},{"key":"2491_CR7","doi-asserted-by":"crossref","first-page":"e1003694","DOI":"10.1371\/journal.pmed.1003694","volume":"18","author":"X Wei","year":"2021","unstructured":"Wei X, Zhang Z, Chong MKC, et al. Evaluation of a package of risk-based pharmaceutical and lifestyle interventions in patients with hypertension and\/or diabetes in rural China: a pragmatic cluster randomised controlled trial. PLoS Med. 2021;18:e1003694.","journal-title":"PLoS Med."},{"key":"2491_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-981-15-4272-5_18","volume":"1207","author":"J Miao","year":"2020","unstructured":"Miao J, Zang X, Cui X, et al. Autophagy, hyperlipidemia, and atherosclerosis. Adv Exp Med Biol. 2020;1207:237\u201364.","journal-title":"Adv Exp Med Biol"},{"key":"2491_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11883-010-0117-4","volume":"12","author":"A Lewis","year":"2010","unstructured":"Lewis A, Segal A. Hyperlipidemia and primary prevention of stroke: does risk factor identification and reduction really work? Curr Atheroscler Rep. 2010;12:225\u20139.","journal-title":"Curr Atheroscler Rep"},{"key":"2491_CR10","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383\u20139.","journal-title":"Lancet"},{"key":"2491_CR11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/STROKEAHA.109.547869","volume":"40","author":"K Asplund","year":"2009","unstructured":"Asplund K, Karvanen J, Giampaoli S, et al. Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project. Stroke. 2009;40:2319\u201326.","journal-title":"Stroke"},{"key":"2491_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11883-009-0045-3","volume":"11","author":"LB Goldstein","year":"2009","unstructured":"Goldstein LB. Statins and ischemic stroke severity: cytoprotection. Curr Atheroscler Rep. 2009;11:296\u2013300.","journal-title":"Curr Atheroscler Rep"},{"key":"2491_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.atherosclerosis.2015.01.030","volume":"239","author":"M Rosvall","year":"2015","unstructured":"Rosvall M, Persson M, \u00d6stling G, et al. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malm\u00f6 Diet and Cancer Study. Atherosclerosis. 2015;239:615\u201321.","journal-title":"Atherosclerosis"},{"key":"2491_CR14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5551\/jat.41533","volume":"25","author":"S Wada","year":"2018","unstructured":"Wada S, Koga M, Toyoda K, et al. Factors associated with intima-media complex thickness of the common carotid artery in Japanese noncardioembolic stroke patients with hyperlipidemia: the J-STARS Echo Study. J Atheroscler Thromb. 2018;25:359\u201373.","journal-title":"J Atheroscler Thromb"},{"key":"2491_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ene.13409","volume":"25","author":"JF Meschia","year":"2018","unstructured":"Meschia JF, Brott T. Ischaemic stroke. Eur J Neurol. 2018;25:35\u201340.","journal-title":"Eur J Neurol"},{"key":"2491_CR16","first-page":"15","volume":"23","author":"A Guzik","year":"2017","unstructured":"Guzik A, Bushnell C. Stroke Epidemiology and risk factor management. Continuum (Minneap Minn). 2017;23:15\u201339.","journal-title":"Continuum (Minneap Minn)"},{"key":"2491_CR17","first-page":"7197054","volume":"2020","author":"C Wang","year":"2020","unstructured":"Wang C, Du Z, Ye N, et al. Using the atherogenic index of plasma to estimate the prevalence of ischemic stroke within a general population in a rural area of China. BioMed Res Int. 2020;2020:7197054.","journal-title":"BioMed Res Int"},{"key":"2491_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2016.04.095","volume":"215","author":"Z Li","year":"2016","unstructured":"Li Z, Bai Y, Guo X, et al. Alcohol consumption and cardiovascular diseases in rural China. Int J Cardiol. 2016;215:257\u201362.","journal-title":"Int J Cardiol"},{"key":"2491_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12944-020-01331-6","volume":"19","author":"S Yu","year":"2020","unstructured":"Yu S, Guo X, Li GX, et al. Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China. Lipids Health Dis. 2020;19:152.","journal-title":"Lipids Health Dis"},{"key":"2491_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12872-015-0060-y","volume":"15","author":"S Chen","year":"2015","unstructured":"Chen S, Guo X, Zhang X, et al. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study. BMC Cardiovasc Disord. 2015;15:65.","journal-title":"BMC Cardiovasc Disord"},{"key":"2491_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hlc.2016.06.1212","volume":"26","author":"N Zhang","year":"2017","unstructured":"Zhang N, Chen Y, Guo X, et al. Metabolic abnormalities, but not metabolically healthy obesity, are associated with left ventricular hypertrophy. Heart Lung Circ. 2017;26:251\u20137.","journal-title":"Heart Lung Circ"},{"key":"2491_CR22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12872-020-01768-8","volume":"20","author":"Z Du","year":"2020","unstructured":"Du Z, Xing L, Lin M, et al. Estimate of prevalent ischemic stroke from triglyceride glucose-body mass index in the general population. BMC Cardiovasc Disord. 2020;20:483.","journal-title":"BMC Cardiovasc Disord"},{"key":"2491_CR23","unstructured":"Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:390\u2013419."},{"key":"2491_CR24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1192\/bjp.bp.110.081331","volume":"197","author":"KS Kendler","year":"2010","unstructured":"Kendler KS, Gardner CO. Interpretation of interactions: guide for the perplexed. Br J Psychiatry. 2010;197:170\u20131.","journal-title":"Br J Psychiatry"},{"key":"2491_CR25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/ije\/dym157","volume":"36","author":"MJ Knol","year":"2007","unstructured":"Knol MJ, van der Tweel I, Grobbee DE, et al. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36:1111\u20138.","journal-title":"Int J Epidemiol"},{"key":"2491_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","volume":"20","author":"T Andersson","year":"2005","unstructured":"Andersson T, Alfredsson L, K\u00e4llberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575\u20139.","journal-title":"Eur J Epidemiol"},{"key":"2491_CR27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00001648-199605000-00012","volume":"7","author":"SF Assmann","year":"1996","unstructured":"Assmann SF, Hosmer DW, Lemeshow S, et al. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286\u201390.","journal-title":"Epidemiology"},{"key":"2491_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","volume":"17","author":"R Li","year":"2007","unstructured":"Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17:227\u201336.","journal-title":"Ann Epidemiol"},{"key":"2491_CR29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/oxfordjournals.aje.a113015","volume":"112","author":"KJ Rothman","year":"1980","unstructured":"Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467\u201370.","journal-title":"Am J Epidemiol"},{"key":"2491_CR30","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.","journal-title":"PLoS Med."},{"key":"2491_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15448","author":"L M'Barek","year":"2021","unstructured":"M\u2019Barek L, Sakka S, Megdiche F, et al. Traditional risk factors and combined genetic markers of recurrent ischemic stroke in adults. J Thromb Haemost. 2021. https:\/\/doi.org\/10.1111\/jth.15448.","journal-title":"J Thromb Haemost"},{"key":"2491_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/HJH.0000000000000753","volume":"34","author":"TC Turin","year":"2016","unstructured":"Turin TC, Okamura T, Afzal AR, et al. Hypertension and lifetime risk of stroke. J Hypertens. 2016;34:116\u201322.","journal-title":"J Hypertens"},{"key":"2491_CR33","doi-asserted-by":"crossref","first-page":"e198103","DOI":"10.1001\/jamanetworkopen.2019.8103","volume":"2","author":"R Zhang","year":"2019","unstructured":"Zhang R, Zhong C, Zhang Y, et al. Immediate antihypertensive treatment for patients with acute ischemic stroke with or without history of hypertension: a secondary analysis of the CATIS randomized clinical trial. JAMA Netw Open. 2019;2:e198103.","journal-title":"JAMA Netw Open"},{"key":"2491_CR34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MOL.0000000000000051","volume":"25","author":"UJ Tietge","year":"2014","unstructured":"Tietge UJ. Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis. Curr Opin Lipidol. 2014;25:94\u20135.","journal-title":"Curr Opin Lipidol"},{"key":"2491_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/postgradmedj-2019-136961","volume":"96","author":"YQ Huang","year":"2020","unstructured":"Huang YQ, Huang JY, Liu L, et al. Relationship between triglyceride levels and ischaemic stroke in elderly hypertensive patients. Postgrad Med J. 2020;96:128\u201333.","journal-title":"Postgrad Med J"},{"key":"2491_CR36","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2174\/1381612826666200614180958","volume":"26","author":"YL Chow","year":"2020","unstructured":"Chow YL, Teh LK, Chyi LH, et al. Lipid metabolism genes in stroke pathogenesis: the atherosclerosis. Curr Pharm Des. 2020;26:4261\u201371.","journal-title":"Curr Pharm Des"},{"key":"2491_CR37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrcardio.2010.96","volume":"7","author":"ME Safar","year":"2010","unstructured":"Safar ME. Arterial aging\u2013hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010;7:442\u20139.","journal-title":"Nat Rev Cardiol"},{"key":"2491_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdiacomp.2013.09.007","volume":"28","author":"ME Atabek","year":"2014","unstructured":"Atabek ME, Aky\u00fcrek N, Eklioglu BS, et al. Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients. J Diabetes Complicat. 2014;28:51\u20135.","journal-title":"J Diabetes Complicat"},{"key":"2491_CR39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/ATVBAHA.113.301220","volume":"33","author":"Q Huang","year":"2013","unstructured":"Huang Q, Qin L, Dai S, et al. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2013;33:795\u2013804.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2491_CR40","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/ATVBAHA.112.249318","volume":"32","author":"M Kassan","year":"2012","unstructured":"Kassan M, Gal\u00e1n M, Partyka M, et al. Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler Thromb Vasc Biol. 2012;32:1652\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2491_CR41","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.3892\/mmr.2015.4066","volume":"12","author":"HY Yang","year":"2015","unstructured":"Yang HY, Bian YF, Zhang HP, et al. LOX-1 is implicated in oxidized low-density lipoprotein-induced oxidative stress of macrophages in atherosclerosis. Mol Med Rep. 2015;12:5335\u201341.","journal-title":"Mol Med Rep"},{"key":"2491_CR42","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00004872-200306000-00011","volume":"21","author":"JF Ndisang","year":"2003","unstructured":"Ndisang JF, Wang R. Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats. J Hypertens. 2003;21:1117\u201324.","journal-title":"J Hypertens"},{"key":"2491_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11883-016-0632-z","volume":"18","author":"J Hurtubise","year":"2016","unstructured":"Hurtubise J, McLellan K, Durr K, et al. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr Atheroscler Rep. 2016;18:82.","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl 4","key":"2491_CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2337\/diacare.14.4.33","volume":"14","author":"GM Reaven","year":"1991","unstructured":"Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care. 1991;14(Suppl 4):33\u20138.","journal-title":"Diabetes Care"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02491-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02491-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T16:03:04Z","timestamp":1644768184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02491-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2491"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02491-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,13]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of China Medical University (Shenyang, China) approved the research protocol. Subjects who had undergone preliminary screening and examination were included after signing a written informed consent form, and all data collection and other procedures complied with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}